{
  "input": {
    "mode": "build_counterchain",
    "query": {
      "entity": "Primary ciliary dyskinesia",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_dornase_alfa",
          "name": "Dornase alfa"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_n_acetylcysteine",
          "name": "N-acetylcysteine"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_ivacaftor",
          "name": "Ivacaftor"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azithromycin",
          "name": "Azithromycin"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bromhexine",
          "name": "Bromhexine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_ambroxol",
          "name": "Ambroxol"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_epinephrine",
          "name": "Epinephrine"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_montelukast",
          "name": "Montelukast"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_fluticasone",
          "name": "Fluticasone"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_prolastin",
          "name": "Prolastin"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sildenafil",
          "name": "Sildenafil"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "n_ot_dornase_alfa",
          "type": "Target",
          "label": "OffTargetDornaseAlfa",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_rp_dornase_alfa",
          "type": "Pathway",
          "label": "RiskPathwayDornaseAlfa",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv_dornase_alfa",
          "type": "Phenotype",
          "label": "AdversePhenotypeDornaseAlfa",
          "attrs": {
            "agent": "Skeptic"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_dornase_alfa",
          "target": "n_ot_dornase_alfa",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "潜在的离靶作用"
        },
        {
          "source": "n_ot_dornase_alfa",
          "target": "n_rp_dornase_alfa",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "可能的风险通路"
        },
        {
          "source": "n_rp_dornase_alfa",
          "target": "n_adv_dornase_alfa",
          "relation": "causes",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "导致不良反应"
        },
        {
          "source": "n_adv_dornase_alfa",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "若该风险成立，将抵消净获益"
        }
      ],
      "conflict_hotspots": [
        {
          "topic": "efficacy vs safety",
          "pro_nodes": [
            "n_ot_dornase_alfa"
          ],
          "con_nodes": [
            "n_adv_dornase_alfa"
          ],
          "note": "疗效提升与潜在安全性风险之间的冲突"
        }
      ]
    },
    "counterclaims": [
      {
        "id": "K1",
        "text": "存在靶向其他组织的可能，但疗效不足",
        "confidence": "medium"
      },
      {
        "id": "K2",
        "text": "激活潜在的炎症反应机制，可能导致不良反应",
        "confidence": "medium"
      }
    ],
    "assumptions_challenged": [
      "药物对主要塞性通道的有效性是否被证实",
      "临床试验中的安全性指标是否充足"
    ],
    "falsification_tests": [
      "是否有证据证明使用 Dornase alfa 的长期安全性",
      "是否有临床数据显示其对主要症状的影响"
    ],
    "next_focus_for_pi": [
      "要求 Proponent 提供 Dronase alfa 的独立作用数据",
      "针对冲突热点进行深入评估"
    ]
  }
}